LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma-Reference-Cited by-同舟云学术

LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma

Published:2016-08-16 Issue:11 Volume:139 Page:2529-2539
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Marshall Amy D.¹²,van Geldermalsen Michelle²³,Otte Nicholas J.²³,Anderson Lyndal A.²⁴,Lum Trina⁴,Vellozzi Melissa A.¹²,Zhang Blake K.²³,Thoeng Annora¹²,Wang Qian²³,Rasko John E.J.¹²⁵,Holst Jeff²³

Affiliation:

1. Gene and Stem Cell Therapy Program; Centenary Institute, University of Sydney; Camperdown New South Wales Australia

2. Sydney Medical School; University of Sydney; Sydney New South Wales Australia

3. Origins of Cancer Program; Centenary Institute, University of Sydney; Camperdown New South Wales Australia

4. Department of Tissue Pathology and Diagnostic Oncology; Royal Prince Alfred Hospital; Camperdown New South Wales Australia

5. Cell and Molecular Therapies; Royal Prince Alfred Hospital; Sydney New South Wales Australia

Funder

National Breast Cancer Foundation

Prostate Cancer Foundation of Australia

Cancer Institute NSW

Cancer Council NSW

Cure the Future and an Anonymous Foundation

University of Sydney HMR+ Implementation Fund

Sydney Catalyst

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30371/fullpdf

Reference50 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Kurman RJ Caracangiu ML Herrington CS World Health Organization Classification of Tumours of Female Reproductive Organs 4th ed

3. Mortality from Western cancers rose dramatically among African-Americans during the 20th century: Are dietary animal products to blame?;McCarty;Med Hypotheses,2001

4. Epidemiologic studies of cancer in minority groups in the western United States;Thomas;Natl Cancer Inst Monogr,1979

5. Nutrient-based dietary patterns and endometrial cancer risk: An Italian case-control study;Bravi;Cancer Epidemiol,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CENPA promotes glutamine metabolism and tumor progression by up-regulating SLC38A1 in endometrial cancer;Cellular Signalling;2024-05

2. The LAT1 inhibitor JPH203 suppresses the growth of castration‐resistant prostate cancer through a CD24‐mediated mechanism;Cancer Science;2024-04-24

3. Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer;Scientific Reports;2023-08-23

4. Metabolic reprogramming and interventions in endometrial carcinoma;Biomedicine & Pharmacotherapy;2023-05

5. Identification of a novel prognostic gene signature in high-grade lung neuroendocrine tumors;2023-01-09